glp-1 drug liraglutide may protect against dementia Five Unexpected New Uses for
Description
DPP-4 degrades GLP-1, leading to the formation of biologically inactive metabolites [10]
Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia
2018(Licence: CC BY-NC-SA 3.0 IGO)
Kaolin intake For the Wistar pica study, rats were group-housed (34 rats per cage) and allowed to acclimatize to the HM-2 system (MBRose) for 7 days before the study start
Retatrutide NAFLD: phase 2 trial results in subset of patients with obesity and NAFLD
Funding source (industry vs
